About

Our Mission
This activity is designed for medical oncologists, hematologists, and other health care providers involved in the management of patients with multiple myeloma and other solid tumors such as breast, lung, and prostate cancer.

The goals of this activity are to increase awareness among the participants about:

1. The importance of monitoring bone health in patients with bone metastases being treated with chemotherapy agents
2. The existing options to appropriately treat bone loss as a result of recurring chemotherapy treatment

This type of community-based forum allows for online collaborative education and learning. Health care providers benefit from this type of education because materials can be viewed on their own time, and they have the ability to share knowledge and ideas with others from the oncology community.

This online forum creates a sense of belonging, further enhancing the desire to participate and learn.

Thank you for your participation and comments. Your knowledge and feedback provided on this forum will ultimately help to increase patient care.

Disclaimer
This Web site is provided on an “as is” basis, without any warranties or conditions, expressed or implied, including but not limited to warranties of merchantable quality, merchantability or fitness for a particular purpose, or those arising by law, statute, usage of trade, or course of dealing. The entire risk as to the results and performance of the Website is assumed by you. Every effort has been made to faithfully produce the accurate information. However, no responsibility is assumed by the Contributing Faculty, Novartis, or the Publisher (M2 Communications, Inc.) for any injury and/or damage to persons or property as a matter of product liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Because of the rapid advances in the medical sciences, we recommend that independent verification of diagnostic methods, therapeutic methods, results of research, and measurement of medical doses should be made. The opinions expressed herein are those of the authors and do not necessarily represent the views of the Sponsor or the Publisher. Please review complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacological therapy to patients.

M2 Communications, Inc., reserves the right to utilize path management software to ensure the appropriate use of technology and log activity of a viewing life cycle. This information is confidential and will be used solely for internal use.

 
 

Jointly Sponsored by Postgraduate Institute for Medicine
and M2 Communications, Inc.

 

Supported by an educational grant from Novartis.

 
This activity has been planned and produced in accordance with the ACCME Essentials.